ABVC CIK: 1173313

ABVC Biopharma Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.60
FY22:
−7.40
FY23:
−4.19
FY24:
−1.81
FY25:
−2.99
Change from FY21 to FY25
millions USD
FY21:
−0.81
FY22:
−1.72
FY23:
−0.36
FY24:
–
FY25:
−1.21
Change from FY21 to FY25
millions USD
FY21:
10.00
FY22:
4.01
FY23:
3.87
FY24:
1.98
FY25:
4.64
millions USD
FY21:
1.56
FY22:
−5.17
FY23:
−0.67
FY24:
0.15
FY25:
0.46
(positive)
Change from FY21 to FY23
millions USD
FY21:
−7.62
FY22:
−7.52
FY23:
−4.21
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR